Evoke Pharma
EVOK
$0.45
Share price
2.27%
Change (1 day)
-76.68%
Change (1 year)
Categories
Evoke Pharma (EVOK) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $9.64 M
According to Evoke Pharma 's latest financial reports the company's total liabilities are $9.64 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Evoke Pharma - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $7.76 M | 10.67% |
| 2021-12-31 | $7.01 M | -44.52% |
| 2020-12-31 | $12.64 M | 527.7% |
| 2019-12-31 | $2.01 M | 23.29% |
| 2018-12-31 | $1.63 M | -71.7% |
| 2017-12-31 | $5.77 M | 4.89% |
| 2016-12-31 | $5.5 M | -9.24% |
| 2015-12-31 | $6.06 M | 0.38% |
| 2014-12-31 | $6.04 M | 58.93% |
| 2013-12-31 | $3.8 M | -80.77% |
| 2012-12-31 | $19.77 M | 6.55% |
| 2011-12-31 | $18.55 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ANI Pharmaceuticals ANIP | $0.44 B | 4,531.21% | 🇺🇸 USA |
 Amphastar Pharmaceuticals AMPH | $0.87 B | 8,953.52% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | $0.53 B | 5,492.53% | 🇺🇸 USA |
 Ironwood Pharmaceuticals
IRWD | $0.81 B | 8,371.82% | 🇺🇸 USA |